Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effektene av eksentrisk sammenlignet med standard styrketrening i primær rehabilitering av ryggmargsskader (KREHA3)

25. september 2026 oppdatert av: Swiss Paraplegic Research, Nottwil

Effektene av eksentrisk sammenlignet med standard styrketrening i primær rehabilitering av ryggmargsskader - et samsvarende par randomisert kontrollert studie

The goal of this clinical trial is to assess the effects of eccentric arm-crank (KREHA) training compared to standard clinical routine strength (STAN) training in individuals undergoing primary spinal cord injury (SCI) rehabilitation.

The main questions this trail aims to answer are:

  • what are the effects of the training on upper body strength, aerobic performance, muscle volume, functional independence, and health-related quality of life?
  • is the KREHA training feasible to implement into the rehabilitation routine?

Participants will:

  • perform either 20 KREHA sessions or 20 STAN sessions within 12 weeks
  • perform a test battery to collect data on training effects before (pretest) and after (posttest) the study intervention

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

20

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Canton of Lucerne
      • Nottwil, Canton of Lucerne, Sveits, 6207
        • Swiss Paraplegic Centre

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • 18 years or older.
  • informed consent as confirmed per signature.
  • traumatic or disease-related SCI.
  • participating in the routine strength training program during primary SCI rehabilitation at the study center (generally this is initiated around one month after SCI onset).
  • wheelchair dependency during activities of daily living, defined by a score of 0-2 in the SCIM subsection regarding "Mobility in the house".
  • passed sports medical assessment and having sufficient biceps/triceps function to perform arm-crank training, as determined by an experienced sports medicine physician

Exclusion Criteria:

  • inflammatory or neurodegenerative diseases (including multiple sclerosis or Guillain-Barré syndrome).
  • comorbidities or other health issues that may interfere with study participation, inability or contraindications to undergo the investigated intervention.
  • MRI contraindications (magnetic metal parts or electronic implants such as pacemakers in the body).
  • pregnancy (anamnestic).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Eccentric arm-crank (KREHA) training

The eccentric training intervention consists of 20 training sessions performed on a symmetric arm-crank (Krafttraining mittels exzentrischer Handkurbel, KREHA) device. The training sessions have a duration of approximately 30 min and will be completed within twelve weeks, with a maximum of three sessions per week.

20 eccentric resistance training sessions will be performed on a symmetric arm-crank ergometer in a supine position.

Aktiv komparator: Standard clinical routine strength (STAN) training

The standard strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. The training sessions have a duration of approximately 60 min and will be completed within twelve weeks, with around three sessions per week.

The regular strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Upper body strength
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Change in upper body strength will be measured by a one-repetition maximum (1RM) bench press (in kg). The maximum amount of weight that can be pushed upwards for one repetition, while lying in a supine position on a weight training bench.

< 1 week pre and 12 weeks post intervention start.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Upper body strength
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Change in upper body strength measured by a 1RM bench pull (in kg). The maximum amount of weight that can be pulled upwards for one repetition, while lying in a prone position on a weight training bench.

< 1 week pre and 12 weeks post intervention start.
Handgrip strength
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Change in maximum strength of three handgrip measurements (in kg) of both hands using a Jamar Handgrip Dynamometer.

< 1 week pre and 12 weeks post intervention start.
Aerobic performance
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Change in cardiopulmonary adaptations, measured by aerobic performance in an exercise test on a regular arm-crank ergometer. A ramp protocol starting at 20 Watt followed by 1 Watt / 6 sec increments to failure will be used. The following parameters will be evaluated during this aerobic endurance test: power at failure at the end of the test (in Watt), peak oxygen uptake during the test (in ml/kg/min), maximal heart rate (bpm)

< 1 week pre and 12 weeks post intervention start.
Muscle volume
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Magnetic resonance imaging (MRI) of relevant upper body muscles of the dominant upper arm and shoulder will be used to measure change in muscle volume.

< 1 week pre and 12 weeks post intervention start.
Arm circumference
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Change in arm circumference of the right and left lower and upper arm (in cm), will be used to estimate muscle volume.

< 1 week pre and 12 weeks post intervention start.
Functioning during activities of daily living
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Change in functioning during activities of daily living will be assessed by the Spinal Cord Independence Measure (SCIM) as extracted from clinical records. The SCIM total score ranges from 0-100, with higher scores indicating higher levels of functional independence.

< 1 week pre and 12 weeks post intervention start.
Health-related quality of life
Tidsramme: < 1 week pre and 12 weeks post intervention start.

Change in health-related quality of life will be assessed using the Short Form Health Survey (SF-12). Weighted physical and mental component scores range from 0-100, with higher scores indicating better physical or mental health.

< 1 week pre and 12 weeks post intervention start.

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Feasibility of the KREHA training (total number of training sessions)
Tidsramme: Throughout the intervention phase, week 0-12

Successful implementation of the KREHA training in the clinical routine, by assessing whether the 20 KREHA sessions are completed within 12 weeks.

Throughout the intervention phase, week 0-12
Feasibility of the KREHA training progression (number of sessions adapted)
Tidsramme: Throughout the intervention phase, week 0-12

Feasibility of the KREHA training progression, by assessing how many training sessions needed to be adapted.

Throughout the intervention phase, week 0-12
Feasibility of the KREHA training progression (power adaptation)
Tidsramme: Throughout the intervention phase, week 0-12

Feasibility of the KREHA training progression, by assessing how much the target power (in Watts) of a training session needed to be adapted compared to the initially planned progression.

Throughout the intervention phase, week 0-12

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. desember 2026

Primær fullføring (Antatt)

1. desember 2028

Studiet fullført (Antatt)

1. desember 2028

Datoer for studieregistrering

Først innsendt

5. mars 2025

Først innsendt som oppfylte QC-kriteriene

28. mars 2025

Først lagt ut (Faktiske)

1. april 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

28. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

25. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2023-21
  • SNCTP000006132 (Annen identifikator: Swiss National Clinical Trials Portal)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere